









Markets
/
Stocks
/
nasdaq-dxcm
/

Dexcom Inc

DXCM

View Detailed Chart

81.990USD

-0.860-1.04%

Close 06/13, 16:00（ET）Quotes delayed by 15 min

32.15BMarket Cap

55.79P/E TTM



Dexcom Inc

81.990

-0.860-1.04%

Company

Intraday

30m

Today

-1.04%

5 Days

-5.40%

1 Month

-4.30%

6 Months

+6.22%

Year to Date

+5.43%

1 Year

-29.29%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 27 analysts

BUY

Current Rating

99.729

Target Price

21.64%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

112

Total

Median

Average

Company name

Ratings

Analysts

Dexcom Inc

DXCM

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Insulet Corp

PODD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(2)

Buy(3)

Indicators

Sell(1)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.853

Neutral

RSI(14)

45.799

Neutral

STOCH(KDJ)(9,3,3)

12.736

Oversold

ATR(14)

2.050

High Vlolatility

CCI(14)

-202.616

Oversold

Williams %R

90.799

Oversold

TRIX(12,20)

0.246

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

83.666

Sell

MA10

84.865

Sell

MA20

85.281

Sell

MA50

77.755

Buy

MA100

79.479

Buy

MA200

76.611

Buy

News

More news coming soon, stay tuned...

Company

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Ticker SymbolDXCM

CompanyDexcom Inc

CEOMr. Kevin R. Sayer

Websitehttps://www.dexcom.com/